Episode Details

Back to Episodes
[SPECIAL EDITION - VIDEO] AI vs. Cancer & Incurable Disease: What Google, Anthropic, OpenAI, Microsoft & Isomorphic Have Actually Proven (Oct 13, 2026)

[SPECIAL EDITION - VIDEO] AI vs. Cancer & Incurable Disease: What Google, Anthropic, OpenAI, Microsoft & Isomorphic Have Actually Proven (Oct 13, 2026)

Season 42 Episode 32 Published 1 day, 2 hours ago
Description

🎧 Listen ADS-FREE: https://podcasts.apple.com/us/podcast/djamgamind-executive-ai-intelligence-business-forensics/id1885359791

🌐 Daily Briefing: https://djamgamind.com/daily

📚 Research Hub: https://djamgamind.com/pdfs

Every major AI lab now says it's fighting disease. We checked the claims against the original research. The AI-discovered drug furthest along in human trials comes from none of them, and the top cancer-AI company hasn't dosed a patient yet.

In this episode:

  • Google: DeepSomatic found 10 new mutations in childhood leukemia samples; an NHS mammography AI caught 25% of missed interval cancers across 125,000 women.
  • Microsoft: GigaTIME turns a $5 pathology slide into a tumour immune map across 24 cancer types.
  • Anthropic: Claude designed working protein binders for 14 of 15 targets, including cancer targets. Lab tests only; Claude Science launched in June.
  • Isomorphic Labs: cancer-first pipeline, no human trial yet, valuation talks at $40-50B.
  • Insilico: AI-discovered rentosertib for incurable lung fibrosis is in a 320-patient Phase III.
  • OpenAI & Biohub: GPT-Rosalind for drug discovery; a $1.8B virtual-cell effort with DeepMind and Meta.
  • The translation ladder: none of the AI-discovered treatments covered is approved yet.

For information only, not medical advice.

Sources & links: https://enoumen.substack.com

🤝 Advertise on AI Unraveled & DjamgaMind: Put your enterprise AI brand in front of the CTOs, CISOs and engineering leaders who make AI buying decisions. Daily, in English and French, across 6 podcast feeds, YouTube and Substack. Sponsorship tiers & media kit: https://djamgamind.com/partners

🔗 TOOLS FROM THE SHOW

⚗️ Researched & produced by Etienne Noumen, P.Eng. (Calgary, Canada) with a hybrid "Human-in-the-Loop" workflow.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us